In 2018, Winawer et al. [56] identified five somatic (probably pathogenic) variants in SLC35A2 from a cohort of 58 individuals with RE (18 with non-lesional focal epilepsy and 38 with focal malformations of cortical development). Here, SLC35A2 is linked to focal epilepsy.